Sanford Sklar
Pulmonary Disease · Farmington Hills, MINPI 1356349427
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Grifols USA, LLC accounts for 76.5% of it on its own, with 18 other manufacturers making up the rest.
Across 122 payments — averaging $53.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols USA, LLC$5K
- GSK$318
- Sunovion Pharmaceuticals Inc.$284
- Boehringer Ingelheim$199
- Regeneron Healthcare Solutions, Inc.$191
- Arbor Pharmaceuticals, Inc.$127
- plus $428 from 13 others
What the payments were for
- Speaking & faculty fees$2,75042%
- Travel & lodging$1,61325%
- Food & beverage$2,20534%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols USA, LLC | 16 | $5,029 |
| GSK | 29 | $318 |
| Sunovion Pharmaceuticals Inc. | 25 | $284 |
| Boehringer Ingelheim | 13 | $199 |
| Regeneron Healthcare Solutions, Inc. | 5 | $191 |
| Arbor Pharmaceuticals, Inc. | 9 | $127 |
| Mylan Specialty L.p. | 6 | $104 |
| United Therapeutics Corporation | 3 | $51 |
| Grifols Shared Services North America, Inc. | 1 | $48 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Electromed, Inc. | 2 | $29 |
| Sanofi | 2 | $29 |
| Insmed, Inc. | 2 | $27 |
| Circassia Inc. | 2 | $26 |
| CSL Behring | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Advanced Respiratory, Inc | 1 | $16 |
| Merck | 1 | $14 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolastin-C$4,094
- Prolastin-C Liquid$813
- DUPIXENT$122
How this compares
$6,575 in reported general payments places this provider in the 70th percentile of 463 pulmonary disease providers in Michigan.
Other pulmonary disease in Farmington Hills
- Muhammad EhteshamFarmington Hills$21K
- Irina ShanidzeFarmington Hills$20K
- Mohammed FarraFarmington Hills$20K
- Meilan HanAnn Arbor$779K
- Njira LugogoAnn Arbor$741K
- Gustavo Cumbo NacheliGrand Rapids$724K
- Gary FergusonLivonia$601K
- Justin OldhamAnn Arbor$392K
- Mounir GhaliWyoming$371K
- Kevin FlahertyAnn Arbor$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.